missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Primary Opalescence Suspension Solution, Fisher Chemical™
Click to view available options
Quantity:
100 mL
Description
- Pharmacopoeia reagents are intended for use in pharmacopoeia testing and monographs, produced under a GMP compliant ISO 9001 quality management system according to the relevant pharmacopoeia specification, using the pharmacopoeia reagent quality components and water meeting the relevant pharmacopoeia monograph requirement for Purified Water. Some pharmacopoeia standards are also accredited according to ISO 17025 and ISO Guide 43.
Specifications
Specifications
| Quantity | 100 mL |
Safety and Handling
Product Identifier
- Primary opalescence suspension. As specified in Chapter 2.2.1. of the European Pharmacopoeia. (OP 001)
- Danger
- Skin sensitiser Category 1
- Carcinogenicity Category 1B
- LONG-TERM AQUATIC HAZARD Chronic 3
- H317-May cause an allergic skin reaction.
- H350-May cause cancer.
- H412-Harmful to aquatic life with long lasting effects.
- P201-Obtain special instructions before use.
- P202-Do not handle until all safety precautions have been read and understood.
- P261-Avoid breathing dust/fume/gas/mist/vapours/spray.
- P272-Contaminated work clothing should not be allowed out of the workplace.
- P273-Avoid release to the environment.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P302+P352-IF ON SKIN: Wash with plenty of water/.
- P308+P313-IF exposed or concerned: Get medical advice/attention.
- P333+P313-If skin irritation or rash occurs: Get medical advice/attention.
- P362+P364-Take off contaminated clothing and wash it before reuse.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
missing translation for 'provideContentCorrection'
missing translation for 'productTitle'